This observation suggests that cancer cells can acquire resistance against AzadC by modifying their DDR and that inhibition of a few specific DNA repair proteins like PARP1 might lead to initially promising synergistic effects but can be overcome quickly. The gene discussed is PARP1; the disease is cancer.